Accordingly, we also found that TGFBI KO in SKOV3 and Caov-3 cells led to decreased expression of MMP-2 (Fig. 4), which inferred that TGFBI had the potential of remodeling ECM in ovarian cancer microenvironment. This evidence concerns the gene MMP2 and ovarian carcinoma.